PCA
TMO icon

Personal Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Personal Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.03M Buy
3,679
+96
+3% +$50.9K 0.01% 213
2022
Q3 		$1.82M Buy
3,583
+180
+5% +$101K 0.01% 208
2022
Q2 		$1.85M Sell
3,403
-65
-2% -$35.8K 0.01% 212
2022
Q1 		$2.05M Sell
3,468
-86
-2% -$49.4K 0.01% 218
2021
Q4 		$2.34M Buy
3,554
+1,050
+42% +$656K 0.01% 220
2021
Q3 		$1.43M Buy
2,504
+39
+2% +$21.4K 0.01% 239
2021
Q2 		$1.24M Buy
2,465
+69
+3% +$32.6K 0.01% 246
2021
Q1 		$1.09M Sell
2,396
-24
-1% -$11.5K 0.01% 252
2020
Q4 		$1.13M Buy
2,420
+455
+23% +$213K 0.01% 244
2020
Q3 		$868K Buy
1,965
+31
+2% +$12.8K 0.01% 253
2020
Q2 		$701K Buy
1,934
+310
+19% +$104K 0.01% 240
2020
Q1 		$393K Buy
1,624
+233
+17% +$73.5K ﹤0.01% 267
2019
Q4 		$452K Buy
1,391
+504
+57% +$153K ﹤0.01% 274
2019
Q3 		$258K Buy
887
+97
+12% +$27.8K ﹤0.01% 311
2019
Q2 		$232K Buy
790
+5
+0.6% +$1.38K ﹤0.01% 296
2019
Q1 		$215K Buy
+785
New +$195K ﹤0.01% 310
2018
Q2 		– Sell
-1,019
Closed -$210K – 284
2018
Q1 		$210K Buy
+1,019
New +$214K ﹤0.01% 252

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Personal Capital Advisors's TMO Position: Q4 2022 in Review

Personal Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 2.7% in Q4 2022, buying an estimated $50.9K and bringing the position to 3,679 shares worth $2.03M. The position accounts for 0.01% of the portfolio, ranked #213.

Personal Capital Advisors first reported a position in TMO in Q1 2018 and has held it in 17 quarters since. The position peaked at $2.34M in Q4 2021. 2,376 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Personal Capital Advisors held 3,679 shares of Thermo Fisher Scientific worth $2.03M as of Q4 2022.
  • Personal Capital Advisors bought 96 Thermo Fisher Scientific shares in Q4 2022, an estimated $50.9K.
  • Thermo Fisher Scientific made up 0.01% of Personal Capital Advisors's portfolio in Q4 2022, its #213 holding.
  • Personal Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 17 quarters since.
  • Personal Capital Advisors's Thermo Fisher Scientific position peaked at $2.34M in Q4 2021.
  • 2,376 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.